⚠ For research purposes only — not for human consumption. Not evaluated by the FDA.
10mg
Tesamorelin is a synthetic GHRH analog investigated in body composition and metabolic pathway research. Studied for growth hormone-releasing mechanisms and metabolic effects.
Published clinical research has examined subcutaneous administration at 1–2 mg per study period for 8–12 week protocols. Refer to published literature for full study methodology. This information is for research reference only.
⚠ This information is from published scientific literature and is provided strictly for research reference. Not for human use. Follow all applicable laws and institutional protocols.
FDA-approved for HIV-associated lipodystrophy. Extensively studied for body composition and metabolic effects. Strong safety profile in clinical research. Works via GHRH receptor — natural stimulation of the HGH axis.
Bacteriostatic water is required to reconstitute lyophilized peptides for research applications.